Haben Sie sich noch nicht registriert? Hier kostenlos Ihr Konto eröffnen.
Passwort vergessen? Wir werden Ihnen einen Zurücksetzen Link senden
8 September 2022
AAVantgarde Bio Appoints Dr. Natalia Misciattelli as Chief Executive Officer
30 Juni 2022
Sofinnova Partners: AAVantgarde Announces the Appointment of Naveed Shams, M.D., Ph.D. as Chief Development and Medical Officer
20 April 2022
Sofinnova Partners Announces New Investment in Nephris, an Innovative Biotech Targeting Chronic Kidney Diseases
7 April 2022
Gradient Denervation Technologies Announces Appointment of Martin Grasse as Chief Executive Officer
31 März 2022
AAVantgarde Bio appoints Ram Palanki as Chairman of its Board of Directors
31 Januar 2022
Sofinnova Partners: SafeHeal Closes €40 Million Financing Co-Led by Sofinnova Partners and Genesis MedTech To Finance Its Colovac Device Through a Pivotal Clinical Trial in the United States